This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

GUNNAR B. STICKLER, MD
Department of Pediatrics Mayo Clinic Rochester, MN 55905

Am J Dis Child. 1988;142(1):14.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—It is possible that I missed something in the article by Tsuru and associates¹ in the January issue of AJDC.

The authors gave the so-called Z scores of linear length before and after treatment of patients with hypophosphatemic rickets. This indicates that the patients were 2.2 SDs below the mean at the age of 2 years and 2.7 SDs below the mean at 12 years. In other words, over the span of observations, their short stature has not changed. This is precisely what I have seen over the years with various forms of treatment in this disease. Growth velocity data do not indicate what the eventual height of these children will be. My colleagues Drs Howard, Huse, and Hayles and I² presented in an abstract our experience treating 16 children for periods from one to seven years with buffered phosphate, ergocalciferol (vitamin D₂), or dihydrotachysterol. The . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?